Zydus Pharmaceuticals (USA) Inc recalls Verapamil Hydrochloride Injection, USP 5 mg / 2mL(2.5 mg/mL), packaged as (a) 25x2 mL Single-Dose Vial per carton, Vial…

Recall date

July 2, 2024

Source

U.S. Food & Drug Administration (FDA) — enforcement report

Recall number

D-0592-2024

FDA classification

Class III

Brand / firm

Zydus Pharmaceuticals (USA) Inc

Sold / distributed

Nationwide in the USA

Why it was recalled

Cross contamination with other products.

Class III means the product violates regulations but is not likely to cause harm.

What was recalled

Verapamil Hydrochloride Injection, USP 5 mg / 2mL(2.5 mg/mL), packaged as (a) 25x2 mL Single-Dose Vial per carton, Vial NDC: 70710-1643-1; Carton NDC 70710-1643-7; (b) 5x2 mL Single-Dose Vial per carton, Vial NDC: 70710-1643-1; Carton NDC 70710-1643-5; Rx Only, Manufactured by: Zydus Lifesciences Ltd. Vadodara, India, Distributed by: Zydus Pharmaceuticals (USA)Inc., Pennington, NJ 08534,